Vertex claimed the two drugs in the deal could eventually bring in more than $5 billion annually. Still, the high price it ...
Vertex Pharmaceuticals is buying an endocrine treatment specialist for $10 billion.
Women who have close family members with endocrine diseases--including type 2 diabetes, thyroid diseases and polycystic ovary syndrome (PCOS)--are at higher risk of pregnancy loss, a new study has ...
Credit: Getty Images We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS. Artificial ...
The deal values Crinetics at $85 per share in cash, representing a potential upside of about 100% from the stock’s closing ...
Women who have close family members with endocrine diseases, including type 2 diabetes, thyroid diseases and polycystic ovary syndrome (PCOS), are at higher risk of pregnancy loss, a new study has ...
Last week, I wrote about the decade-long campaign to rename the condition known as polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). The change recognizes that the ...
Adverse cognitive effects linked to polychlorinated biphenyls (PCBs) exposure, a type of endocrine-disrupting chemical (EDC), have the potential to be passed down through generations, according to an ...
Diabetes and thyroid disorders occur due to hormonal changes. Although growing evidence suggests a link between diabetes and thyroid disorders, researchers are currently unsure what connects them.